Cipla partners with Hetero to launch biosimilar anaemia drug
New Delhi: Pharma major Cipla on Thursday announced a collaboration with Hetero Drugs to launch a medication under the Actorise brand for treatment of anaemia caused due to chronic kidney disease.
"The collaboration stands as a multi-partner co- marketing deal which offers Cipla a license to make the drug accessible to a wide number of patients in India," the company said in a statement.
Actorise is a biosimilar of 'Darbepoetin alfa', which is marketed by US-based Amgen under the brand Aranesp.
Cipla said Actorise is available in the pre-filled syringes (PFS) in the strengths of 25 mcg and 40 mcg priced at Rs 1,500 and Rs 2,200 respectively.
Commenting on the development, Cipla Chief Medical Officer Jaideep Gogtay said: "The launch of Darbepoetin alfa reinforces our strong commitment to expand the product pipeline in biosimilars and to increase product access in various therapeutic areas."
The company anticipates more number of deals across therapy areas in the near future, he added.
"More than 1,00,000 patients each year need renal replacement therapy -- dialysis and renal transplant. Most of these patients develop anaemia and will need drugs such as Darbepoetin alfa to maintain their hemoglobin and reduce the need for blood transfusions," Gogtay said.
Darbepoetin alfa, a second generation erythropoietin maintains the hemoglobin levels for a longer period of time, and so the dose is only once a week, Cipla said.
Mumbai based Cipla's portfolio includes 2,000 products in 65 therapeutic categories.
Shares of Cipla were trading at Rs 424.30 per scrip in the afternoon trade on BSE, down 0.20 per cent from it's previous close.
More from India
More from World
More from Sports
More from Entertaiment
More from Health
- PM Narendra Modi's speech at Heart of Asia conference
- India-Afghanistan thrash Pakistan over terrorism issue in Heart of Asia conference
- Gujarat: Goods train engine catches fire in Surat
- Tamil Nadu CM Jayalalithaa's condition extremely grave
- Tamil Nadu CM Jayalalithaa suffers cardiac arrest; being monitored
- Fake or Real? 'Alien animal' caught on Karnataka-Kerala border
- People want to know whether Jayalalithaa is alive or not; PM Narendra Modi must intervene, says expelled AIADMK MP Sasikala Pushpa
- Tamil Nadu CM Jayalalithaa's condition continues to remain critical after suffering cardiac arrest
- Jayalalithaa's health condition: Amma critical, nation's political fraternity expresses concern - Who said what
- Jayalalithaa's health condition: AIADMK member from Cuddalore dies after seeing news about Tamil Nadu CM's cardiac arrest